KROS

KROS Operating Expenses

$115.68MTTM · USD

Period ending:

KROS FY Operating ExpensesUSD
KROS FY Operating Expenses2018-12-31: $11.32M2019-12-31: $20.01M2020-12-31: $46.05M2021-12-31: $76.47M2022-12-31: $114.79M2023-12-31: $170.09M2024-12-31: $214.38M2025-12-31: $171.93M$214.38M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

KROS operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Keros Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
171,929,000
214,383,000
170,092,000
114,790,000
76,473,000
46,052,000
20,005,000
11,321,000

Compare operating expenses

All KROS financial metrics · KROS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.